Analysis of cell‐free circulating DNA fragment size and level in patients with lumbar canal stenosis

Cell‐free circulating DNA (cfDNA), extracted by liquid biopsy, has been studied as a noninvasive biomarker for various diseases. The potential of cfDNA fragment size and level as a marker in lumbar canal stenosis (LCS) patients has never been studied. We investigated whether cfDNA is a biomarker of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiyama, Akihiko, Sakai, Daisuke, Nomura, Satoshi, Katoh, Hiroyuki, Watanabe, Masahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238277/
https://www.ncbi.nlm.nih.gov/pubmed/35783906
http://dx.doi.org/10.1002/jsp2.1189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238277/
https://www.ncbi.nlm.nih.gov/pubmed/35783906
http://dx.doi.org/10.1002/jsp2.1189

Ejemplares similares